Biosimilar launch in the retina space

I am a member of the inaugural ophthalmology sales force to educate uveitis specialists, ocular immunologists, cornea and retina specialists about a specialized injectable, H.P. Acthar Gel. It is indicated for a range of ophthalmic inflammatory diseases. My territory includes Texas, Oklahoma, and Arkansas* #1 ophthalmology sales rep in 2016 Presidents Club 2016* #1 ophthalmology sales rep in 2017Presidents Club 2017* #1 ophthalmology sales rep in 2018Presidents club 2018#1 ophthalmology sales rep in 2019 Presidents club 2019

Executive specialty sales representative focusing on general ophthalmologists, retina, glaucoma, cornea specialist and optometrists selling post operative eye drops and allergy drops. Successfully launched 4 products: Besivance & Zirgan, Lotemax Gel, & Prolensa

Launched Twinject in November 2005 and exceeded sales goals. Twinject is an epinephrine injectable device for life-threatening allergies. Exclusively responsible for sales, training Twinject to medical staff for a new territory. Outside specialty sales targeting multiple markets including, high volume physicians: Allergists, ENT’s, hospitals, educational facilities, regional pharmacies, managed care and government sites.Territory: Oklahoma and Arkansas with a travel of 30-40%.

Outside pharmaceutical sales targeted toward physicians specializing in Primary Care, Allergists, Endocrinologists, Cardiologists, Pain specialist, Orthopedic Surgeons, Pediatricians and Obstetricians in the Dallas, Texas area. Developed 2 previously un-established territories while exceeding sales goals in several highly competitive markets. Exclusively responsible for sales, distribution and marketing a product portfolio including: Entex LA, Anexia CIII, Embrex 600`, Altoprev, and Fortamet. Proven specialized sales experience in the Cardiology and Diabetes market. Successfully completed two new product launches for Atoprev (Lovastatin XR) and Fortamet (Metformin XR).